Insider · CIK 0002020260
James Nisco
officer
Files at LSTA (LISATA THERAPEUTICS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 27,956 | Jan 13, 2025 |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | FTax withholding Common Stock | -2,131 | $3.80 | $8,098 | 25,825 | Jan 13, 2025 |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | FTax withholding Common Stock | -1,137 | $3.80 | $4,321 | 24,688 | Jan 13, 2025 |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | FTax withholding Common Stock | -781 | $3.80 | $2,968 | 23,907 | Jan 13, 2025 |
| Jan 10, 2025 | LSTA LISATA THERAPEUTICS, INC. | FTax withholding Common Stock | -416 | $3.73 | $1,552 | 23,491 | Jan 13, 2025 |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +7,000 | $0.00 | $0 | 7,000 | Jan 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.